GABRA2 and Anxiety: The Gabra2–1 mutation demonstrates a striking parallel with the effects of ARHGEF9 mutation in human syndromes, whose symptoms include epilepsy, anxiety, mental retardation, aggressive behavior, sleep–wake cycle disruptions, early mortality, and hyperekplexia24–27.